Next Article in Journal
MAL2-Induced Actin-Based Protrusion Formation is Anti-Oncogenic in Hepatocellular Carcinoma
Previous Article in Journal
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
Article

Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression

1
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli 35053, Taiwan
2
National Taiwan Ocean University, Keelung 20224, Taiwan
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(2), 421; https://doi.org/10.3390/cancers12020421
Received: 18 January 2020 / Accepted: 10 February 2020 / Published: 12 February 2020
Reactive oxygen species (ROS) produced during intracellular metabolism or triggered by extrinsic factors can promote neoplastic transformation and malignant microenvironment that mediate tumor development. Oligo-Fucoidan is a sulfated polysaccharide isolated from the brown seaweed. Using human THP-1 monocytes and murine Raw264.7 macrophages as well as human HCT116 colorectal cancer cells, primary C6P2-L1 colorectal cancer cells and human MDA-MB231 breast cancer cells, we investigated the effect of Oligo-Fucoidan on inhibiting M2 macrophage differentiation and its therapeutic potential as a supplement in chemotherapy and tumor prevention. We now demonstrate that Oligo-Fucoidan is an antioxidant that suppresses intracellular ROS and mitochondrial superoxide levels in monocytes/macrophages and in aggressive cancer cells. Comparable to ROS inhibitors (DPI and NAC), Oligo-Fucoidan directly induced monocyte polarization toward M1-like macrophages and repolarized M2 macrophages into M1 phenotypes. DPI and Oligo-Fucoidan also cooperatively prevented M2 macrophage invasiveness. Indirectly, M1 polarity was advanced particularly when DPI suppressed ROS generation and supplemented with Oligo-Fucoidan in the cancer cells. Moreover, cisplatin chemoagent polarized monocytes and M0 macrophages toward M2-like phenotypes and Oligo-Fucoidan supplementation reduced these side effects. Furthermore, Oligo-Fucoidan promoted cytotoxicity of cisplatin and antagonized cisplatin effect on cancer cells to prevent M2 macrophage differentiation. More importantly, Oligo-Fucoidan inhibited tumor progression and M2 macrophage infiltration in tumor microenvironment, thus increasing of anti-tumor immunity. View Full-Text
Keywords: Oligo-Fucoidan; antioxidant; cisplatin; ROS; M1/M2 macrophages; tumor progression Oligo-Fucoidan; antioxidant; cisplatin; ROS; M1/M2 macrophages; tumor progression
Show Figures

Figure 1

MDPI and ACS Style

Chen, L.-M.; Tseng, H.-Y.; Chen, Y.-A.; Al Haq, A.T.; Hwang, P.-A.; Hsu, H.-L. Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression. Cancers 2020, 12, 421. https://doi.org/10.3390/cancers12020421

AMA Style

Chen L-M, Tseng H-Y, Chen Y-A, Al Haq AT, Hwang P-A, Hsu H-L. Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression. Cancers. 2020; 12(2):421. https://doi.org/10.3390/cancers12020421

Chicago/Turabian Style

Chen, Li-Mei, Hong-Yu Tseng, Yen-An Chen, Aushia T. Al Haq, Pai-An Hwang, and Hsin-Ling Hsu. 2020. "Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression" Cancers 12, no. 2: 421. https://doi.org/10.3390/cancers12020421

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop